Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.
作者信息
Elbe Dean, Barr Alasdair M, Honer William G, Procyshyn Ric M
机构信息
Pharmacy Department BC Children's Hospital and Children's & Women's Mental Health Programs BC Mental Health & Substance Use Services Vancouver, BC, Canada.
Department of Anesthesiology, Pharmacology & Therapeutics University of British Columbia British Columbia Mental Health and Addictions Research Institute Vancouver, BC, Canada.
出版信息
J Psychiatry Neurosci. 2014 May;39(3):E32-3. doi: 10.1503/jpn.130288.
Abstract
摘要
相似文献
1
Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.联合使用精神兴奋剂和抗精神病药物治疗多动症及破坏性行为障碍
J Psychiatry Neurosci. 2014 May;39(3):E32-3. doi: 10.1503/jpn.130288.
2
A Naturalistic Comparison of Methylphenidate and Risperidone Monotherapy in Drug-Naive Youth With Attention-Deficit/Hyperactivity Disorder Comorbid With Oppositional Defiant Disorder and Aggression.哌甲酯与利培酮单药治疗初治的注意缺陷/多动障碍合并对立违抗障碍及攻击行为的青少年的自然主义比较
J Clin Psychopharmacol. 2017 Oct;37(5):590-594. doi: 10.1097/JCP.0000000000000747.
3
Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.利培酮在患有注意力缺陷多动障碍、其他破坏性行为障碍以及智商低于平均水平的儿童中，在使用/不使用精神兴奋剂药物情况下的效果。
J Child Adolesc Psychopharmacol. 2004 Summer;14(2):243-54. doi: 10.1089/1044546041649020.
4
Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.治疗儿童严重攻击行为时共病的焦虑和社交回避：对在兴奋剂和家长培训基础上加用利培酮的反应；破坏性行为症状反应的中介作用
J Child Adolesc Psychopharmacol. 2015 Apr;25(3):203-12. doi: 10.1089/cap.2014.0104.
5
Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression.参加家长培训及参与度可预测接受药物治疗的注意力缺陷/多动障碍和严重攻击行为儿童的行为结果。
J Child Adolesc Psychopharmacol. 2019 Mar;29(2):90-99. doi: 10.1089/cap.2018.0119. Epub 2018 Dec 28.
6
Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression.一项关于兴奋剂、家长培训和利培酮治疗严重身体攻击行为儿童的研究中的参与者满意度。
J Child Adolesc Psychopharmacol. 2015 Apr;25(3):225-33. doi: 10.1089/cap.2014.0097.
7
The Relationship between Acute Dyskinesia with a Single Dose of Methylphenidate and Recent Risperidone Discontinuation in a Child with Attention-Deficit/Hyperactivity Disorder.一名注意力缺陷/多动障碍儿童单次服用哌醋甲酯后急性运动障碍与近期停用利培酮之间的关系
J Child Adolesc Psychopharmacol. 2015 May;25(4):378-9. doi: 10.1089/cap.2014.0148. Epub 2015 Apr 28.
8
Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder.共病症状学调节了患有严重攻击行为、破坏性行为障碍和注意力缺陷/多动障碍的儿童对利培酮、兴奋剂和家长培训的反应。
J Child Adolesc Psychopharmacol. 2015 Apr;25(3):213-24. doi: 10.1089/cap.2014.0109.
9
Not just another antipsychotic-for-conduct-problems trial.不仅仅是另一项关于抗精神病药物治疗行为问题的试验。
J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):17-20. doi: 10.1016/j.jaac.2013.10.007.
10
Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder.冷酷无情特质、主动攻击行为与注意缺陷/多动障碍攻击性儿童的治疗结果
J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1281-93. doi: 10.1016/j.jaac.2013.08.024. Epub 2013 Sep 25.
引用本文的文献
1
Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review.长效注射用抗精神病药治疗早期精神病：全面系统综述。
PLoS One. 2022 Apr 29;17(4):e0267808. doi: 10.1371/journal.pone.0267808. eCollection 2022.
2
In vitro pharmacological characterization of SPN-810M (molindone).SPN - 810M（吗茚酮）的体外药理学特性
J Exp Pharmacol. 2018 Nov 21;10:65-73. doi: 10.2147/JEP.S180777. eCollection 2018.
3
Low-dose quetiapine complements stimulant response in attention deficit hyperactivity disorder and more.低剂量喹硫平可增强注意力缺陷多动障碍及其他病症对兴奋剂的反应。
Ther Adv Psychopharmacol. 2016 Dec;6(6):384-385. doi: 10.1177/2045125316672545. Epub 2016 Oct 13.
本文引用的文献
1
Prevalence and patterns of antipsychotic use in youth at the time of admission and discharge from an inpatient psychiatric facility.住院精神科设施入院和出院时青少年抗精神病药物使用的流行情况和模式。
J Clin Psychopharmacol. 2014 Feb;34(1):17-22. doi: 10.1097/JCP.0b013e3182a607dd.
2
Antipsychotic and psychostimulant drug combination therapy in attention deficit/hyperactivity and disruptive behavior disorders: a systematic review of efficacy and tolerability.抗精神病药和精神兴奋剂联合治疗注意缺陷/多动障碍和破坏性行为障碍：疗效和耐受性的系统评价。
Curr Psychiatry Rep. 2013 May;15(5):355. doi: 10.1007/s11920-013-0355-6.
3
Ten years of antipsychotic prescribing to children: a Canadian population-based study.抗精神病药物治疗儿童十年：一项加拿大基于人群的研究。
Can J Psychiatry. 2012 Jan;57(1):52-8. doi: 10.1177/070674371205700109.
4
Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth.关于监测儿童和青少年第二代抗精神病药物安全性的循证建议。
J Can Acad Child Adolesc Psychiatry. 2011 Aug;20(3):218-33.
5
The dopamine dilemma: using stimulants and antipsychotics concurrently.多巴胺困境：同时使用兴奋剂和抗精神病药物。
Psychiatry (Edgmont). 2010 Jun;7(6):18-23.
6
A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic.一项针对注意力缺陷多动障碍门诊中使用非典型抗精神病药物的预测因素及风险的自然主义研究。
J Child Adolesc Psychopharmacol. 2009 Oct;19(5):575-82. doi: 10.1089/cap.2009.0050.
7
Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality.在患有具有临床相关性攻击行为或对立行为的青少年中，兴奋剂与第二代抗精神病药物联合使用对体重增加、代谢变化、催乳素水平及镇静作用无影响。
J Child Adolesc Psychopharmacol. 2009 Oct;19(5):563-73. doi: 10.1089/cap.2009.0051.
8
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.德克萨斯儿童药物治疗算法项目：注意缺陷/多动障碍药物治疗算法的修订
J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):642-657. doi: 10.1097/01.chi.0000215326.51175.eb.
9
International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.关于注意力缺陷多动障碍（ADHD）和破坏性行为障碍（DBDs）的国际共识声明：临床意义及治疗实践建议
Eur Neuropsychopharmacol. 2004 Jan;14(1):11-28. doi: 10.1016/s0924-977x(03)00045-2.
10
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.针对有攻击行为青少年使用抗精神病药物的治疗建议（TRAAY）。第二部分。
J Am Acad Child Adolesc Psychiatry. 2003 Feb;42(2):145-61. doi: 10.1097/00004583-200302000-00008.
Zotero 插件